(Q38410120)

English

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial

scientific article published on 09 June 2015

Statements

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial (English)
Patrick S Parfrey
Yumi Kubo
Geoffrey A Block
Ricardo Correa-Rotter
Tilman B Drüeke
Charles A Herzog
Gerard M London
David C Wheeler
Maria Stolina
Bastian Dehmel
William G Goodman
Jürgen Floege
Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*
9 June 2015
27-39

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit